PL Thomas ‘s GliSODin(R) Supplement Shown to Be a Preventive Agent against Atherosclerosis in Individuals with Metabolic Syndrome

MORRISTOWN, N.J.--(BUSINESS WIRE)--PL Thomas (PLT) today, in association with Isocell, Paris, France, announced the results of a new study using their exclusive dietary supplement ingredient, GliSODin®, in the European Annals of Allergy and Clinical Immunology. GliSODin supplementation, in combination with healthy diet and lifestyle modifications, significantly inhibited the progression of cardiovascular risk factors compared to diet and modifications alone.

MORE ON THIS TOPIC